Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office
Asefa, Wosene wosene.asefa@nih.gov 240-276-6422	5E504	Program Support Assistant \| Chemopreventive Agent Development
Biswas, Kajal, Ph.D. kajal.biswas2@nih.gov 240-276-5614	5E540	Program Officer \| Chemopreventive Agent Development
Cholewa, Brian, Ph.D. brian.cholewa@nih.gov 240-276-7545	5E446	Deputy Chief \| Chemopreventive Agent Development
Clifford, John, Ph.D. john.clifford@nih.gov 202-235-4482	5E430	Program Officer \| Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D. vignesh.gunasekharan@nih.gov 240-276-5814	5E438	Program Officer \| Chemopreventive Agent Development
Mohammed, Altaf, Ph.D. altaf.mohammed@nih.gov 240-276-6082	5E542	Deputy Chief \| Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S. ancy.nalli@nih.gov 202-276-5265	5E536	Program Officer \| Chemopreventive Agent Development
Sei, Shizuko, M.D. shizuko.sei@nih.gov 240-276-5005	5E452	Co-Chief \| Chemopreventive Agent Development
Shoemaker, Robert, Ph.D. robert.shoemaker@nih.gov 240-276-7077	5E454	Co-Chief \| Chemopreventive Agent Development Acting Chief \| Nutritional Science
Vlad, Anda, M.D., Ph.D. anda.vlad@nih.gov 240-276-6422	5E538	Program Officer \| Chemopreventive Agent Development

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Whitman, Eric	Atlantic Health System, Inc. United States	The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC Corp)	3UG1CA239772-06S1	Vanessa A. White, M.P.H.
Wildman-Tobriner, Benjamin	Duke University United States	AI for Differentiation of Low vs High Risk Thyroid Nodules on Ultrasound	1R01CA297227-01A1	Wendy Wang, Ph.D., M.Sc.
Wilkin, Timothy J.	University Of California, San Diego United States	Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub)	5UG1CA275414-05	Maria Silvina Frech, Ph.D., M.S.
Williams, Paige L	Harvard University D/B/A Harvard School Of Public Health United States	Pediatric HIV/AIDS Cohort Study (PHACS) 2020	3P01HD103133-05S1	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Wilson, Michael R	Wayne State University United States	Does obesity influence protein quality control in endometrial cancer?	5R00CA252152-05	Amit Kumar, Ph.D.
Winer, Rachel L.	University Of Washington United States	The CASCADE CLIMB: Cervical cancer prevention in women Living with HIV research Mobilization Base	5UG1CA275402-04	Maria Silvina Frech, Ph.D., M.S.
Winger, Joseph Giles	Duke University United States	Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer	5R01CA291768-02	Brennan Streck, Ph.D., RN, M.P.H.
Winters-Stone, Kerri M	Oregon Health & Science University United States	Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer	5R01CA248059-05	Goli Samimi, Ph.D., M.P.H.
Wolpin, Brian Matthew	Dana-Farber Cancer Inst United States	Altered metabolism and machine learning for pancreatic cancer early detection	5U01CA210171-09	Matthew Young, Ph.D.
Wong, David T	University Of California Los Angeles United States	EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment	4U01CA233370-08	Nicholas Hodges, Ph.D.
Wright, Alexi A	Dana-Farber Cancer Inst United States	Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitors	5R01CA289547-02	Goli Samimi, Ph.D., M.P.H.
Wu, Yun	State University Of New York At Buffalo United States	Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay	4R01CA272827-04	Christos Patriotis, Ph.D., M.Sc.
Xiao, Yi	University Of Tx Md Anderson Can Ctr United States	Exploring new strategy for breast cancer immunoprevention by targeting histamine receptor H1	5R21CA286318-02	Anda Vlad, M.D., Ph.D.
Xu, Xiangxi Mike	University Of Miami School Of Medicine United States	Countering microtubule stabilization within hair follicles in ovarian cancer chemotherapy	5R01CA286527-02	Rachel Altshuler, Ph.D.
Xu, Chunhui	Emory University United States	High-throughput assessment of chemotherapy-induced cardiotoxicity in 3D human cardiomyocytes	1R21CA285254-01A1	Eileen Dimond, R.N., M.S.

Chemopreventive Agent Development

On This Page

Major Programs

Staff List

Grants